Clowes Howard reported option exercise involving 921 shares of CERENOME, INC. at $0.00 for $0 on Oct 1, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Oct 1, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
921Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
2,902Direct
Trade date
Oct 1, 2026Option exercise
Filed
Oct 1, 2026, 8:00 AM ET0-day reporting delay
Accession
0001193125-26-409860Code M · Transaction 232338
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Oct 1, 2026Option exercise921$0.00$0Trade 232339
2 transaction rows in this filing. Joint filers share the same rows.

CNSY price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CNSY · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d +0.6%30d −4.5%90d180d1y

Footnotes in full

F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's Common Stock. F2: Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026.